Moneycontrol PRO
HomeNewsBusinessMoneycontrol ResearchGodrej Consumer Products: International business remains a drag; stay on the sidelines

Godrej Consumer Products: International business remains a drag; stay on the sidelines

January 30, 2019 / 11:08 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Anubhav Sahu
    Moneycontrol Research

    Highlights:
    - Pricing-led growth, but weak volume growth on a high base
    - International business witnesses sharp margin erosion
    - Household Insecticides remains stagnant
    - Q4 to see improved margin as crude oil impact eases
    - Re-rating potential hinges on credible international performance
     -------------------------------------------------

    Godrej Consumer Products has reported a comparable constant currency growth of 8 percent, aided by 10 percent and 6 percent growth in the international and India business, respectively. While the India business benefitted from pricing effect, cost saving initiatives helped in EBITDA margin expansion of 140 bps YoY (100 basis points=1 percentage point).

    Result snapshot
    Capture
    Source: Company

    Key negatives
    In terms of volume growth -- the key metric for FMCG companies -- its domestic business performance was disappointing. Volume growth of just one percent came on a base of 18 percent. Its two-year CAGR volume growth stands at 10 percent. In terms of segments, soaps (2 percent year-on-year) and hair colours (flattish YoY) witnessed a moderate sales performance on a high base of 24 percent and 33 percent, respectively. In Q2, the soaps segment posted five consecutive quarters of double-digit sales growth.

    Adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) margin for the international business of 14.6 percent ( down 300 bps YoY) was weighed by both crude oil and currency depreciation. Overall, comparable constant currency EBITDA growth of two percent was weaker than its FMCG peers.

    Key observations
    Household insecticides segment (38 percent of India sales) continued to see stagnate with two year sales CAGR of a mere 3 percent. The company noted flat growth in Q3 mainly driven by unfavourable season in south India, which accounts for one-third of segment sales. However, this is in contrast to growth seen by Jyothy Laboratories in this segment in Q3 (12 percent YoY). The management highlighted that the share of growth is getting diverted to incense sticks, which is a new sub-segment initiated by the company recently.

    The management estimates that on account of illegal incense stick business growth of around 4-5 percent has been taken off from the household insecticides business. The category should have seen 6-8 percent growth if there was no adverse effect of illegal products on this business. Godrej Consumer has also embarked in this sub-segment with the launch of Goodknight Naturals Neem Agarbatti, in Andhra Pradesh and Telangana.

    International topline is improving on a sequential basis led by Indonesia (32 percent of international sales). The management expects near-term growth to be aided by series of new launches. Key challenge here is the gestation period required for creating a credible position. Currently, a significant share of operating cost goes towards upfront marketing and sales promotion.

    In case of South Africa, the management said the worst is over and that the company should be able to tackle competitive intensity going forward.

    OutlookSales growth in the quarter under review was guided by pricing effect. However, the same was expected to taper in the near term, in line with the sector. Volume growth should rebound in Q4 as the base effect is favourable. On account of better crude oil pricing, the management is hopeful of a margin improvement. Moreover, demand conditions remain stable.

    As far as the stock is concerned, it has consolidated from its recent highs, broadly in line with its peers. It currently trades at 36 times FY20 estimated earnings, which is a discount of about 8-10 percent to the likes Marico and Dabur.

    We feel a relatively higher exposure to international markets (50 percent of sales), wherein growth visibility and earnings stability are lower than the Indian domestic market, warrants a lower multiple. Hence, we stay on the sidelines.

    Follow @anubhavsays

    Disclaimer: Moneycontrol Research analysts do not hold positions in the companies discussed here

    Anubhav Sahu is Principal Research Analyst, Moneycontrol Research. He has been writing research/recommendation pieces on Chemicals and Pharma sectors along with Equity strategy themes. He has previously worked with Credit Suisse and BNP Paribas.
    first published: Jan 30, 2019 11:07 am

    Disclosure & Disclaimer

    This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347